Michelle Magid is a faculty member at the University of Texas Dell Medical School. Her research primarily focuses on mental health issues, specifically depression and the innovative use of botulinum toxin treatment for major depressive disorder. She has contributed significantly to the field of psychiatry through her publications, which include studies on the effectiveness of electroconvulsive therapy and psychodermatology. Magid's work examines the intersection of dermatological and psychological conditions, addressing topics like trichotillomania and the implications of neuromodulators in psychiatric treatments. She has actively published in several esteemed journals and continues to explore new therapeutic approaches within psychiatry, demonstrating a commitment to advancing mental health care.